Keystone Financial Planning Cut Amgen (AMGN) Holding by $1.30 Million; Market Valuation Rose; As Cvs Health (CVS) Valuation Declined, Dowling & Yahnke Has Cut by $693,293 Its Holding

CVS Health Corporation (NYSE:CVS) Logo

Keystone Financial Planning Inc decreased its stake in Amgen (AMGN) by 26.27% based on its latest 2019Q1 regulatory filing with the SEC. Keystone Financial Planning Inc sold 6,856 shares as the company’s stock rose 5.93% . The institutional investor held 19,239 shares of the biological products (no diagnostic substances) company at the end of 2019Q1, valued at $3.66M, down from 26,095 at the end of the previous reported quarter. Keystone Financial Planning Inc who had been investing in Amgen for a number of months, seems to be less bullish one the $119.53 billion market cap company. The stock increased 0.22% or $0.44 during the last trading session, reaching $199.31. About 2.97 million shares traded. Amgen Inc. (NASDAQ:AMGN) has declined 2.12% since August 16, 2018 and is downtrending. It has underperformed by 2.12% the S&P500. Some Historical AMGN News: 24/04/2018 – Amgen, Inc. Sees 2018 Rev $21.9B-$22.8B; 15/05/2018 – #2 PM bureau: Pfizer finally finishes a 3-year regulatory odyssey, bagging an FDA OK for 1st Epogen knockoff $PFE $AMGN $JNJ; 11/04/2018 – Amgen goes back to Rhode Island to build its first next-gen manufacturing site in the US $AMGN @AmberTongPW; 17/04/2018 – New — Blockbuster ambitions: Amgen/Novartis team lines up more promising PhIII erenumab data for some of the toughest migraine patients $AMGN $NVS $LLY; 03/05/2018 – COHERUS BIOSCIENCES – RE-SUBMISSION OF BLA FOR CHS-1701, A PEGFILGRASTIM (NEULASTA®) BIOSIMILAR CANDIDATE, TO U.S. FDA UNDER 351(K) PATHWAY; 17/05/2018 – Amgen: Aimovig Is the First and Only FDA-Approved Treatment to Block the Calcitonin Gene-Related Peptide Receptor; 16/03/2018 – Biotechnology Companies with Great Potential; 09/03/2018 – New Analyses Show Payer Utilization Management Criteria Deny Access To PCSK9 Inhibitors For Patients At The Highest Risk For Subsequent Cardiovascular Events; 06/03/2018 – Amgen Preliminary Proration Factor for Tender Offer Is Approximately 95.9%; 26/03/2018 – Hartford Value HLS Adds Lilly, Exits Amgen

Dowling & Yahnke Llc decreased its stake in Cvs Health Corp (CVS) by 18.86% based on its latest 2019Q1 regulatory filing with the SEC. Dowling & Yahnke Llc sold 13,081 shares as the company’s stock declined 2.55% . The institutional investor held 56,271 shares of the medical and nursing services company at the end of 2019Q1, valued at $3.04 million, down from 69,352 at the end of the previous reported quarter. Dowling & Yahnke Llc who had been investing in Cvs Health Corp for a number of months, seems to be less bullish one the $76.52B market cap company. The stock increased 0.48% or $0.28 during the last trading session, reaching $58.84. About 10.57 million shares traded or 24.40% up from the average. CVS Health Corporation (NYSE:CVS) has declined 17.14% since August 16, 2018 and is downtrending. It has underperformed by 17.14% the S&P500. Some Historical CVS News: 06/03/2018 – S&PGR Downgrades CVS Health To ‘BBB’; Debt Rated ‘BBB’; 06/03/2018 – S&PGR: Could Lower CVS Ratings if There Are Delays in Reducing Leverage; 22/03/2018 – CVS Health Receives NCQA Utilization Management Accreditation; 19/04/2018 – CVS Pharmacy Launches First Campaign Featuring Unaltered Beauty lmagery; 06/03/2018 – Monster CVS Sale Tests IG Yields at Six-Year High: Markets Live; 04/05/2018 – WSVN 7 News: #BREAKING: Jury decides to not press charges in 2017’s fatal CVS shooting in Davie; 02/05/2018 – CVS Gets a Lift From Prescriptions; 20/03/2018 – CVS HEALTH NAMES DERICA W. RICE AS PRESIDENT OF CVS CAREMARK; 23/04/2018 – SOHN CONFERENCE: ROBBINS OF GLENVIEW RECOMMENDS EXPRESS SCRIPTS ESRX.O , CVS HEALTH CVS.N AND MCKESSON CORP MCK.N; 13/03/2018 – CVS Health and Aetna shareholders will vote today on the drugstore chain’s proposed $69 billion acquisition of the health insurer

Dowling & Yahnke Llc, which manages about $2.91B and $1.04 billion US Long portfolio, upped its stake in Vanguard Intl Equity Index F (VNQI) by 5,995 shares to 231,060 shares, valued at $13.76 million in 2019Q1, according to the filing. It also increased its holding in Select Sector Spdr Tr (XLE) by 7,403 shares in the quarter, for a total of 18,029 shares, and has risen its stake in Vanguard Intl Equity Index F (VSS).

Investors sentiment decreased to 1.25 in Q1 2019. Its down 0.64, from 1.89 in 2018Q4. It worsened, as 120 investors sold CVS shares while 415 reduced holdings. 126 funds opened positions while 543 raised stakes. 969.19 million shares or 6.06% less from 1.03 billion shares in 2018Q4 were reported. Marco Inv Mngmt Ltd Liability has invested 0.34% in CVS Health Corporation (NYSE:CVS). Gargoyle Investment Advisor Ltd Limited Liability Company owns 17,046 shares or 0.88% of their US portfolio. Martingale Asset Mngmt LP reported 0% of its portfolio in CVS Health Corporation (NYSE:CVS). Balasa Dinverno & Foltz Lc has 0.04% invested in CVS Health Corporation (NYSE:CVS). Umb Fincl Bank N A Mo accumulated 121,496 shares or 0.2% of the stock. Ontario – Canada-based Royal Bancorp Of Canada has invested 0.2% in CVS Health Corporation (NYSE:CVS). Canal Ins owns 150,000 shares. Strategic Global Advisors Ltd Company holds 0.07% in CVS Health Corporation (NYSE:CVS) or 6,204 shares. Hanson Doremus Investment Mngmt invested in 6,857 shares. Meiji Yasuda Life Ins holds 23,814 shares. Cwm Ltd Limited Liability Company accumulated 0.01% or 5,211 shares. Jane Street Gru Ltd Liability Com reported 678,803 shares. Royal National Bank & Trust Of Scotland Grp Incorporated Public Ltd Llc reported 7,017 shares or 0.08% of all its holdings. Cipher Capital Lp holds 0.05% of its portfolio in CVS Health Corporation (NYSE:CVS) for 11,068 shares. Affinity Invest Advsr Limited Liability Company reported 159,169 shares stake.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Investorplace.com which released: “The Worst Appears to Be Over for CVS Stock – Investorplace.com” on July 18, 2019, also Benzinga.com with their article: “Q2 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios (NYSE:BABA)(NASDAQ:AMZN)(NYSE:BRK) – Benzinga” published on August 15, 2019, Seekingalpha.com published: “CVS Health Is A Bargain – Seeking Alpha” on May 03, 2019. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Benzinga.com and their article: “The State Of CBD Regulation: Clear Rules Or Consumers At Risk? – Benzinga” published on August 02, 2019 as well as Seekingalpha.com‘s news article titled: “CVS Health Q2 2019 Earnings Preview – Seeking Alpha” with publication date: August 06, 2019.

Since March 1, 2019, it had 6 insider buys, and 0 selling transactions for $1.68 million activity. 9,600 shares were bought by DORMAN DAVID W, worth $506,016 on Friday, March 8. LUDWIG EDWARD J also bought $233,080 worth of CVS Health Corporation (NYSE:CVS) on Friday, March 1. Shares for $531,800 were bought by BROWN C DAVID II.

Investors sentiment decreased to 0.88 in Q1 2019. Its down 0.11, from 0.99 in 2018Q4. It is negative, as 70 investors sold AMGN shares while 539 reduced holdings. 131 funds opened positions while 405 raised stakes. 457.12 million shares or 8.22% less from 498.05 million shares in 2018Q4 were reported. Hollencrest reported 3,432 shares stake. Quantum Capital Mgmt holds 5,216 shares or 0.53% of its portfolio. Thompson Siegel And Walmsley Ltd Liability invested in 17,826 shares. Louisiana State Employees Retirement System holds 32,900 shares. 2.49 million are held by Sumitomo Mitsui. D E Shaw & invested in 0.4% or 1.62M shares. 4,958 are owned by Mercer Cap Advisers. Chevy Chase Tru Hldgs Inc holds 533,166 shares. Marble Harbor Investment Counsel Limited Liability Com, Massachusetts-based fund reported 2,573 shares. Fund Mgmt reported 83,051 shares. Roof Eidam & Maycock Adv holds 8,550 shares. Clarivest Asset Mngmt Limited Liability Corp holds 1.03% of its portfolio in Amgen Inc. (NASDAQ:AMGN) for 269,092 shares. Spectrum Mgmt Group Incorporated Inc holds 0.71% of its portfolio in Amgen Inc. (NASDAQ:AMGN) for 12,422 shares. Wilbanks Smith And Thomas Asset stated it has 0.08% of its portfolio in Amgen Inc. (NASDAQ:AMGN). 5,124 are held by Dorsey Whitney Tru Co.

Keystone Financial Planning Inc, which manages about $143.92M and $202.66M US Long portfolio, upped its stake in Cvs Health (NYSE:CVS) by 34,555 shares to 102,673 shares, valued at $5.54 million in 2019Q1, according to the filing. It also increased its holding in Glaxosmithkline (NYSE:GSK) by 23,048 shares in the quarter, for a total of 155,988 shares, and has risen its stake in Altria (NYSE:MO).

More notable recent Amgen Inc. (NASDAQ:AMGN) news were published by: Nasdaq.com which released: “Why Amgen (AMGN) Might Surprise This Earnings Season – Nasdaq” on July 29, 2019, also Nasdaq.com with their article: “Amgen (AMGN) Beats Q2 Earnings and Revenue Estimates – Nasdaq” published on July 30, 2019, Finance.Yahoo.com published: “Introducing Amgen (NASDAQ:AMGN), A Stock That Climbed 50% In The Last Five Years – Yahoo Finance” on May 14, 2019. More interesting news about Amgen Inc. (NASDAQ:AMGN) were released by: Nasdaq.com and their article: “Top Ranked Income Stocks to Buy for August 14th – Nasdaq” published on August 14, 2019 as well as Themiddlemarket.com‘s news article titled: “Strategic buyers snatch up cancer drug developers | Mergers & Acquisitions – Mergers & Acquisitions” with publication date: August 15, 2019.

Amgen Inc. (NASDAQ:AMGN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.